1. Home
  2. IGC vs DTST Comparison

IGC vs DTST Comparison

Compare IGC & DTST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IGC
  • DTST
  • Stock Information
  • Founded
  • IGC 2005
  • DTST 2001
  • Country
  • IGC United States
  • DTST United States
  • Employees
  • IGC N/A
  • DTST N/A
  • Industry
  • IGC Biotechnology: Pharmaceutical Preparations
  • DTST EDP Services
  • Sector
  • IGC Health Care
  • DTST Technology
  • Exchange
  • IGC Nasdaq
  • DTST Nasdaq
  • Market Cap
  • IGC 39.8M
  • DTST 32.6M
  • IPO Year
  • IGC N/A
  • DTST N/A
  • Fundamental
  • Price
  • IGC $0.42
  • DTST $4.19
  • Analyst Decision
  • IGC Strong Buy
  • DTST Hold
  • Analyst Count
  • IGC 2
  • DTST 1
  • Target Price
  • IGC $4.00
  • DTST N/A
  • AVG Volume (30 Days)
  • IGC 695.2K
  • DTST 66.7K
  • Earning Date
  • IGC 11-11-2025
  • DTST 11-13-2025
  • Dividend Yield
  • IGC N/A
  • DTST N/A
  • EPS Growth
  • IGC N/A
  • DTST N/A
  • EPS
  • IGC N/A
  • DTST N/A
  • Revenue
  • IGC $1,327,000.00
  • DTST $25,455,742.00
  • Revenue This Year
  • IGC $15.26
  • DTST $12.57
  • Revenue Next Year
  • IGC $3.41
  • DTST $9.29
  • P/E Ratio
  • IGC N/A
  • DTST N/A
  • Revenue Growth
  • IGC 24.95
  • DTST 0.53
  • 52 Week Low
  • IGC $0.25
  • DTST $2.93
  • 52 Week High
  • IGC $0.50
  • DTST $5.44
  • Technical
  • Relative Strength Index (RSI)
  • IGC 52.73
  • DTST 40.05
  • Support Level
  • IGC $0.39
  • DTST $4.10
  • Resistance Level
  • IGC $0.43
  • DTST $4.42
  • Average True Range (ATR)
  • IGC 0.02
  • DTST 0.15
  • MACD
  • IGC -0.00
  • DTST -0.02
  • Stochastic Oscillator
  • IGC 44.42
  • DTST 20.81

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

About DTST Data Storage Corporation

Data Storage Corporation engages in providing cybersecurity, compliance and cloud computing solutions. The company's segment includes Nexxis Inc; CloudFirst Europe Ltd and CloudFirst Technologies Corporation and Corporate. It generates maximum revenue from the CloudFirst Technologies Corporation segment. The company's solutions include infrastructure, disaster recovery, email archival, compliance, electronic vaulting, virtualized recovery, telecom recovery services, and continuous data protection.

Share on Social Networks: